Fig. 3From: Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolonesDose proportionality of SJ733 and SJ311 as function of AUCinf and Cmax, oral and intravenous dose combined. a Dose proportionality of SJ733 and SJ311 as function of AUCinf in rats. b Dose proportionality of SJ733 and SJ311 as function of AUCinf in mice. c Dose proportionality of SJ733 and SJ311 as function of Cmax in rats. d Dose proportionality of SJ733 and SJ311 as function of Cmax in mice. Unweighted linear regression was performed with GraphPad Prism 8.0Back to article page